Article Details

Enanta Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:ENTA)

Retrieved on: 2020-12-18 12:11:40

Tags for this article:

Click the tags to see associated articles and topics

Enanta Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:ENTA). View article details on hiswai:

Excerpt

BlackRock Inc. now owns 3,215,507 shares of the biotechnology company's stock valued at $147,206,000 after buying an additional 185,216 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo